Cancer stem cells in squamous cell carcinoma switch between two distinct phenotypes that are preferentially migratory or proliferative
- PMID: 21685475
- DOI: 10.1158/0008-5472.CAN-11-1059
Cancer stem cells in squamous cell carcinoma switch between two distinct phenotypes that are preferentially migratory or proliferative
Abstract
Epithelial-to-mesenchymal transition (EMT) is an important driver of tumor invasion and metastasis, which causes many cancer deaths. Cancer stem cells (CSC) that maintain and initiate tumors have also been implicated in invasion and metastasis, but whether EMT is an important contributor to CSC function is unclear. In this study, we investigated whether a population of CSCs that have undergone EMT (EMT CSCs) exists in squamous cell carcinoma (SCC). We also determined whether a separate population of CSCs that retain epithelial characteristics (non-EMT CSCs) is also present. Our studies revealed that self-renewing CSCs in SCC include two biologically-distinct phenotypes. One phenotype, termed CD44(high)ESA(high), was proliferative and retained epithelial characteristics (non-EMT CSCs), whereas the other phenotype, termed CD44(high)ESA(low), was migratory and had mesenchymal traits characteristic of EMT CSCs. We found that non-EMT and EMT CSCs could switch their epithelial or mesenchymal traits to reconstitute the cellular heterogeneity which was characteristic of CSCs. However, the ability of EMT CSCs to switch to non-EMT character was restricted to cells that were also ALDH1(+), implying that only ALDH1(+) EMT cells had the ability to seed a new epithelial tumor. Taken together, our findings highlight the identification of two distinct CSC phenotypes and suggest a need to define therapeutic targets that can eradicate both of these variants to achieve effective SCC treatment.
Similar articles
-
Cancer stem-like cells enriched with CD29 and CD44 markers exhibit molecular characteristics with epithelial-mesenchymal transition in squamous cell carcinoma.Arch Dermatol Res. 2013 Jan;305(1):35-47. doi: 10.1007/s00403-012-1260-2. Epub 2012 Jun 28. Arch Dermatol Res. 2013. PMID: 22740085
-
Elevation in 5-FU-induced apoptosis in head and neck cancer stem cells by a combination of CDHP and GSK3β inhibitors.J Oral Pathol Med. 2015 Mar;44(3):201-7. doi: 10.1111/jop.12230. Epub 2014 Aug 28. J Oral Pathol Med. 2015. PMID: 25169655
-
Phenotypic Plasticity Determines Cancer Stem Cell Therapeutic Resistance in Oral Squamous Cell Carcinoma.EBioMedicine. 2016 Jan 9;4:138-45. doi: 10.1016/j.ebiom.2016.01.007. eCollection 2016 Feb. EBioMedicine. 2016. PMID: 26981578 Free PMC article.
-
Breast cancer stem cells and intrinsic subtypes: controversies rage on.Curr Stem Cell Res Ther. 2009 Jan;4(1):50-60. doi: 10.2174/157488809787169110. Curr Stem Cell Res Ther. 2009. PMID: 19149630 Review.
-
[Encounter of cancer cells with bone. The significance of cancer stem cells and epithelial-mesenchymal transition in tumor invasion and metastasis].Clin Calcium. 2011 Mar;21(3):411-7. Clin Calcium. 2011. PMID: 21358063 Review. Japanese.
Cited by
-
The squamous cell carcinoma cell line OM-1 retains both p75-dependent stratified epithelial progenitor potential and cancer stem cell properties.Biochem Biophys Rep. 2021 May 18;26:101003. doi: 10.1016/j.bbrep.2021.101003. eCollection 2021 Jul. Biochem Biophys Rep. 2021. PMID: 34041369 Free PMC article.
-
Overexpression of ALDH1 and EMT marker profile are linked with unfavorable outcome in head and neck cancer.Med Oral Patol Oral Cir Bucal. 2020 Nov 1;25(6):e752-e761. doi: 10.4317/medoral.23777. Med Oral Patol Oral Cir Bucal. 2020. PMID: 32701933 Free PMC article.
-
HMGA2 elicits EMT by activating the Wnt/β-catenin pathway in gastric cancer.Dig Dis Sci. 2013 Mar;58(3):724-33. doi: 10.1007/s10620-012-2399-6. Epub 2012 Nov 8. Dig Dis Sci. 2013. PMID: 23135750
-
Role of microRNAs in the regulation of breast cancer stem cells.J Mammary Gland Biol Neoplasia. 2012 Mar;17(1):15-21. doi: 10.1007/s10911-012-9242-8. Epub 2012 Feb 14. J Mammary Gland Biol Neoplasia. 2012. PMID: 22331423 Free PMC article.
-
Stromal-derived interleukin 6 drives epithelial-to-mesenchymal transition and therapy resistance in esophageal adenocarcinoma.Proc Natl Acad Sci U S A. 2019 Feb 5;116(6):2237-2242. doi: 10.1073/pnas.1820459116. Epub 2019 Jan 22. Proc Natl Acad Sci U S A. 2019. PMID: 30670657 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous